UPDATE: Solazyme Downgraded by Goldman Sachs on Short-Term Valuation By: Benzinga via Benzinga March 04, 2014 at 11:23 AM EST Goldman Sachs analyst Brian Lee downgraded Solazyme (NASDAQ: SZYM) Tuesday morning, lowering rating from Buy to Neutral and a price ... Read More >>